| Mepha Pharma AG - Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg, Filmtabletten | | 65890 | | 01 | | Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg | | Filmtabletten | | C09DX01 | | Valsartan, Amlodipin und Hydrochlorthiazid | | 02.11.2016 | | |
| | Composition | | amlodipinum 5 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), talcum, E 171, macrogolum 4000, acidi methacrylici copolymerum C, natrii hydrogenocarbonas corresp. natrium 0.005 mg, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Amlodipine | 5 mg | | Hydrochlorothiazide | 12.5 mg | | Valsartan | 160 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Amlodipine | 5 mg | | Hydrochlorothiazide | 12.5 mg | | Valsartan | 160 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici Copolymerum C | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Sodium Hydrogenocarbonate | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
